Dry powder for inhalation comprising a formoterol salt and ciclesonide

Details for Australian Patent Application No. 2004255026 (hide)

Owner Aventis Pharma Limited

Inventors Wayland, Ruth Margaret

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004255026

PCT Pub. Number WO2005/004853

Priority 0315889.6 08.07.03 GB

Filing date 8 July 2004

Wipo publication date 20 January 2005

International Classifications

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/573 (2006.01)

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/004853 Priority application(s): WO2005/004853

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004255029-Multi-dose inhaler

2004255024-Cancer combination therapy comprising AZD2171 and ZD1839